BACKGROUND: The pathophysiological mechanisms underlying premature ovarian failure (POF) are largely unknown. Our objective was to develop a working animal model to explore the pathogenesis of POF. Since galactosaemic women eventually develop POF, we evaluated the potential of experimental galactose toxicity as the proposed model. METHODS: Pregnant rats were fed pellets supplemented with or without 35% galactose from day 3 of conception continuing through weaning of the litters. Female offspring were evaluated for serum levels of galactose and galactose-1-phosphate, growth rate, onset of puberty, reproductive cyclicity, ovarian complement of follicles, hypothalamo-pituitary±ovarian function and follicular response to gonadotrophins. RESULTS: Galactose toxicity delayed the onset of puberty and developed a state of hypergonadotrophic hypoestrogenism. The characteristic low FSH levels at weaning followed by pubertal spurts of gonadotrophins and estradiol (E 2 ) secretion of the controls was replaced by a sustained high level of FSH and a low level of E 2 under galactose toxicity. The ovary developed with apparently normal or de®cient complement of follicles. Ovarian response to exogenous gonadotrophin stimulation was blunted, but the response improved signi®cantly when the stimulation was preceded by pituitary desensitization. CONCLUSION: Experimental galactose toxicity may serve as a model for exploring some of the basic tenets of POF.
Introduction
Premature ovarian failure (POF), a condition causing amenorrhoea and hypergonadotrophic hypoestrogenism before the age of 40 years, affects 1% of women in the general population. POF was once thought to be an irreversible entity, but it has been demonstrated subsequently that in POF, unlike in menopause, residual ovarian function may remain despite the presence of elevated gonadotrophins. Many authorities therefore divide POF patients into two distinct categories: patients with follicle depletion and patients with follicle dysfunction (Anasti, 1998) . The latter condition is characterized by the presence of follicles in the ovary that are unresponsive to gonadotrophins, and is usually referred to as`resistant ovary syndrome' (ROS) (Wentz, 1996) . The general consensus is that ROS is one pathway in the progression to irreversible ovarian failure regardless of the mechanism (Richardson, 1993; Conway, 1997) . A substantial number of patients, perhaps belonging to the latter category, experience spontaneous remission (Alper et al., 1986) . However, except for oocyte donation, no evidence-based effective line of therapy for treatment of the disease is currently available (Fitch et al., 1982) . The therapeutic modalities currently offered to POF patients are only palliative and supportive, rather than curative.
Incomplete knowledge of the precise phenomena underlying the pathogenesis of the disease is the major obstacle in devising effective therapeutic options for POF. The disease demonstrates a wide variety of phenotypes. However, except for genetic disorders or exposure to high dose radiation or chemotherapy, its aetiology remains an enigma and the mechanism of pathogenesis remains largely unknown. Identi®cation of the pathophysiological mechanisms is therefore considered an essential prerequisite for the development of new effective treatment options (Liu et al., 2000) . However, there are limitations in undertaking in-depth studies in humans, and development of a suitable animal model remains a basic need.
A number of reports document that women with galactosaemia eventually develop POF (Kaufman et al., 1988; Waggoner et al., 1990; Guerrero et al., 2000) . The pathophysiological attributes of POF in galactosaemic and other chromosomally competent women are likely to be different, but in both cases the disease possibly progresses through similar clinical pathways (Twigg et al., 1996) . Therefore, investigation of galactosaemic subjects may provide clues to some natural mechanisms underlying the pathogenesis of POF.
The causal link between galactosaemia and POF is not de®nitely known. There are suggestions, however, that prema-ture depletion of ovarian follicular reserve is due to toxic effects of galactose and its metabolites (Cramer et al., 1989) . Earlier reports have documented that feeding large amounts of galactose, which overpowers the normal capacity of the animal to metabolize this sugar, can produce an animal model of galactose toxicity (Gibson, 1995; Segal, 1995) . Rodents exposed to high concentrations of galactose had been the models for the study of gonadal dysfunction in galactosaemia. Adult females and the offspring from dams exposed to galactose were reported to exhibit manifestations of diverse ovarian dysfunction that include delayed onset of puberty, decrease in numbers of ovarian follicles and follicular resistance to gonadotrophins. (Chen et al., 1981; Meyer et al., 1992) . We have demonstrated recently that prenatal exposure to high galactose adversely affects oogonial migration and results in a low initial pool of germ cells in the developing gonads (Bandyopadhyay et al., 2003) . Parallels can be drawn between these speci®c gonadal dysfunctions and POF or ROS components of human galactosaemia. With the foregoing considerations in mind, we reasoned that it should be of considerable interest to explore if experimental galactose toxicity can serve as a model for the investigations on POF/ ROS. The present investigation demonstrates a composite picture of the ovarian dysfunctions under experimental galactose toxicity in rats, and evaluates its suitability as a model to unveil the pathophysiological mechanisms underlying the development of the disease.
Materials and methods

Chemicals and food
The following materials were commercially available: galactose, pregnant mare's serum gonadotrophin (PMSG), HCG, hyaluronidase, chloramine T, b-nicotinamide adenine dinucleotide (b-NAD), a-Dgalactose-1-phosphate (dipotassium salt, type II), p-iodonitrotetrazolium violet, diaphorase (Clostridium kluyveri) (Sigma Chemical Co., St. Louis, MO), alkaline phosphatase (calf intestine) (New England Biolabs, UK), anti-rabbit g-globulin (Genei, Bangalore, India), carrier free [ 125 I]Na (Bhaba Atomic Research Centre, Mumbai, India), buserelin acetate (Hoechst Marion Roussel Ltd, UK) and b-galactose dehydrogenase (Pseudomonas sp.) (Roche Molecular Biochemicals, Germany). Immunoreagents for LH and FSH radioimmunoassay were gifts from the National Hormone and Pituitary Program, NIDDK, Torrance, CA. The chemiluminescence enzyme immunoassay kit for estradiol (E 2 ) estimation was purchased from Chiron Diagnostics Corp., MA. Standard food pellets (carbohydrate, 65.5%; protein, 21%; fat, 5.5%; mineral mixture, 7%; and vitamin mixture, 1%), supplemented with or without 35% galactose, were produced in our own animal house.
Animals
The experiments were performed in accordance with the guidelines formulated by the Committee for the Purpose of Control and Supervision of Experiments on Animals, Ministry of Culture, India, with approval from the Animal Ethics Committee of the Indian Institute of Chemical Biology. Sprague±Dawley rats maintained under good husbandry conditions of food and water ad libitum with a diurnal cycle of 12 h light and 12 h dark starting at 0600 h were raised in our institute animal house. Adult female rats were mated with proven fertile males of the same strain, and the presence of sperm in the vaginal lavage was assigned as day 1 of gestation. They were fed standard food pellets supplemented with (gal-exposed; n = 38) or without (control; n = 24) galactose from day 3 of conception, continuing through weaning of the litters on postnatal day (PND) 21 (PND0 being the day of birth) when the female litters were separated and maintained separately, and employed for the following investigations.
Estimation of galactose and galactose-1-phosphate Blood levels of galactose and galactose-1-phosphate were measured at weaning (PND21) (control, n = 12; gal-exposed, n = 15) as well as adult age (PND70/71) (control, n = 7; gal-exposed, n = 11). Blood was collected by direct cardiac puncture; sera were procured after centrifugation and assayed for simultaneous determination of galactose and galactose-1-phosphate by a colorimetric microassay method. The assay protocol was a modi®cation of that described by Diepenbrock et al. (1992) , wherein measured volumes of sera and standards were used instead of dried blood spots and standards. Measurement was done in the form of galactose alone or with that released from galactose-1-phosphate following co-incubation with alkaline phosphatase and galactose dehydrogenase. The concentrations were expressed as mmol/l.
Assessment of growth rate
If not otherwise mentioned, body weights (BWs) of the litters were recorded every 5th day since birth, and continued throughout the course of the experiments.
Assessment of onset of puberty
The onset of puberty was marked by the time of vaginal opening (VO). From PND35 onward, the rats (control, n = 30; gal-exposed, n = 57) were checked daily for VO. On the day of VO, age and BW of the respective rats were recorded, and during the subsequent course of investigations estrous cyclicity was evaluated by vaginal cytology.
Assessment of ovarian follicular reserve
Ovaries of the 55-to 60-day-old animals were dissected out immediately after sacri®ce, trimmed of fat, weighed and immerse®xed in Bouin's ®xative for 24 h followed by paraf®n embedding and subsequent processing for routine histopathological evaluation under light microscopy.
Assessment of pituitary gonadal functions
Either at weaning on PND21 or on PND42/43, rats were euthenized. Blood was collected by direct cardiac puncture, and serum was separated and stored at ±70°C for subsequent determination of LH, FSH and E 2 .
Serum levels of LH and FSH were measured by a double-antibody radioimmunoassay method. Pure rat LH (NIDDK-rLH-I-9) and FSH (NIDDK-rFSH-I-9) were iodinated with carrier-free 125 I using chloramine T according to the method of Greenwood et al. (1963) . The antisera to LH and FSH were NIDDK-anti-rLH-S-11 and NIDDK-anti-rFSH-S-11, respectively. The sensitivities of the assays were 0.15 ng/ml for LH and 0.5 ng/ml for FSH. All samples were assayed in a single batch at two concentrations, and each in duplicate. The intra-assay coef®cients of variations were <8%. The LH and FSH values were expressed in terms of the reference standards, NIDDKrat-LH-RP-3 and NIDDK-rat-FSH-RP-2.
Serum levels of E 2 were measured by fully automated chemiluminescence assay system, ACS 180 (Chiron Diagnostics Corp., East Walpole, MA). The sensitivity of the assay was 10 pg/ml and the intra-assay coef®cient of variation was 5.6%.
Assessment of follicular response to gonadotrophins
Between PND25 and PND30, control (n = 25) and gal-exposed (n = 35) rats were subjected to induction of the superovulatory response by exogenous gonadotrophins. They had an s.c. injection of 30 IU of PMSG at 0 h. A subset of animals from each group (control, n = 10; gal-exposed, n = 14) were sacri®ced at 50 h when blood was collected, and serum was procured and stored frozen at ±70°C until assessed for E 2 levels. The remaining animals had an s.c. injection of 50 IU of HCG at 52 h followed by autopsy at 72 h when the presence of oocytes in the oviduct was assessed and counted. In another set of control (n = 15) and gal-exposed rats (n = 23), superovulation was effected after induction of pituitary desensitization. The rats had an s.c. injection of 100 mg of GnRH agonist per day in two equal doses for 10 days, and were then subjected to the induction of superovulation by PMSG±HCG. The ovulatory response was assessed with respect to both numbers of rats exhibiting the presence of ovulated oocytes and the numbers of oocytes ovulated per rat stimulated.
Statistics
The data were expressed as mean T SEM, and n refers to the number of animals or determinations. Differences between the groups were analysed by one-way ANOVA, Student's t-test and c 2 tests, as applicable, using the Epistat package (Tracy L.Gustafson, 2011 Cap Rock Circle, Richardson, TX 75080).
Results
Blood levels of galactose and galactose-1-phosphate The study population had signi®cantly elevated levels of galactose (mmol/l) and galactose-1-phosphate (mmol/l) at weaning (galactose, 0.35 T 0.01; galactose-1-phosphate, 0.07 T 0.01) as well as at 70/71 days of age (galactose, 0.38 T 0.02; galactose-1-phosphate, 0.05 T 0.01), compared with almost non-detectable levels of both analytes in the respective control groups.
Growth rate
BWs of the litters at birth and subsequent growth rates are presented in Figure 1 . At birth, the BWs of the pups were not statistically different, although the gal-exposed pups had relatively lower weight. Though both groups exhibited a steady rise in their BW, the rate of growth was signi®cantly lower in the study population throughout the period of study. The difference in the growth rates reached the maximum level of signi®cance during PND30±40 when the control group exhibited a pre-pubertal growth spurt.
Vaginal opening
The timing of VO has been expressed in relation to age (Figure 2A ) as well as BW ( Figure 2B ). The mean age (days) (control 43.4 T 0.45 versus gal-exposed 54.5 T 1.10) and BW (g) (control 78.2 T 1.06 versus gal-exposed 94.4 T 2.26) on Figure 1 . Postnatal growth rates in control and galactose-exposed litters. Both groups show a steady increase in their body weight throughout the course of study, but the galactose-exposed group exhibits a remarkably poor growth rate with no characteristic peripubertal growth spurt. The number of rats used in each point of evaluation was between 15 and 22. Figure 2 . Timing of vaginal opening in control and galactoseexposed litters in relation to their age distribution (A) and body weight (B). CI is the 95% con®dence interval and (n) is the number of rats used. For age, the galactose group (CI 38.3±70.7) were signi®cantly different (P = 0.000001) from control (CI 38.5±48.3). For body weight, the galactose group (CI 60.8±127.9) were signi®cantly different (P = 0.000002) from control (CI 66.8±89.6) the day of VO was signi®cantly (P`0.000002) higher in the study group than in the control group. With a 95% con®dence interval (CI), the age of 67% of the gal-exposed litters on the day of VO was beyond the upper con®dence limit of the control population. In 63% of the gal-exposed rats, VO was delayed although they exceeded the upper BW limit of the control population at the time of VO.
Compared with 4 or 5 day regular estrous cycles in the control group, the gal-exposed group exhibited marked irregularity in the cycles as characterized by increased length, ranging from 8 to 11 days mostly due to prolongation of the diestrous phase, with the sporadic appearance of pro-estrus followed by estrus.
Ovarian histology
Ovarian sections of control rats ( Figure 3A) showed the presence of follicles at different stages of maturation and the corpus luteum (CL). In contrast, the study population exhibited diverse architecture of the ovaries ( Figure 3B and C) . Reduced ovarian mass and absence of graa®an follicle and CL were generalized ®ndings. However, many ovaries were de®cient in small follicles ( Figure 3B ), while the others had an infantile appearance with a normal complement of follicles but with growth and differentiation arrested at the early pre-antral stage ( Figure 3C ). The presence of a large number of pyknotic granulosa cells, arranged in a single symmetric ring adjacent to the basement membrane and offering the structure of a string of beads, marked the preponderance of atretic cells ( Figure 3B ).
Serum levels of gonadotrophins and E 2
Hormone levels are summarized in Table I . The control rats had characteristic low FSH and high E 2 levels at weaning, which was followed by a spurt of FSH and E 2 secretion at the stipulated peri-pubertal phase. The study group, on the other hand, had signi®cantly lower levels of E 2 and elevated gonadotrophins on both occasions. Table II depicts the results of the ovarian response to gonadotrophins. Compared with the control group, the ovarian response to PMSG±HCG with respect to the number of rats ovulated or the rate of oocyte retrieval, and the peak E 2 value on the day of HCG administration were signi®cantly poorer in the study group. When gonadotrophin stimulation was preceded by pituitary desensitization, the ovarian response in the study group improved over its corresponding control group in all respects. However, while the number of rats responding to stimulation (82.6%) almost reached the GnRH agonist control level (86.6%), the oocyte retrieval rate still remained signi®-cantly lower (P = 0.013).
Ovarian response to induction of superovulation
Discussion
To devise effective therapeutic options for POF, further appreciation of the pathophysiological mechanisms of the disease is of prime importance. We therefore decided to develop a suitable animal model that may serve to explore the pathogenesis of the disease.
Women with galactosaemia eventually develop POF (Kaufman et al., 1988; Waggoner et al., 1990; Guerrero et al., 2000) . It has been proposed that the pathogenesis of POF in galactosaemic and other women possibly progresses through similar clinical pathways (Twigg et al., 1996) . Thus, investi- Figure 3 . Histological sections through ovaries of 55-to 60-day old control (A) and galactose-exposed rats (B and C). The control ovary exhibits the presence of follicles at different stages of maturity and a functional corpus luteum (CL). The galactose-exposed ovaries exhibit an infantile appearance with a de®cient state of follicular reserve (B), or the presence of apparently normal complement of unstimulated follicles arrested mostly at the pre-antral stage and a preponderance of atretic follicles (C). The absence of graa®an follicles and CL was the most salient feature. 1, pre-antral or secondary follicles; 2, early antral follicles or vesicular follicles; 3, graa®an follicle; 4, corpus luteum; 5, atretic follicles. Bars = 50 mm.
gations on galactosaemic subjects are likely to unravel some natural mechanisms that may underlie the development of POF (Twigg et al., 1996) .
There is good evidence that galactose readily crosses the placenta (Segal, 1995) . Administration of galactose to rats during pregnancy produces a sequela of abnormalities in the litters which are characteristic of human galactosaemia (Segal and Bernstein, 1963; Spatz and Segal, 1983) . Thus the rodents provide an excellent model system for galactose toxicity, which is easy to acquire, maintain and modulate. We thought it reasonable to evaluate the potentiality of this experimental condition as the proposed model for the present investigation.
Increased levels of galactose and its metabolites are thought to be responsible for most of the toxic manifestations of galactosaemia. To assess the magnitude of galactose toxicity under the prevailing experimental condition with our treatment regimen, we measured the levels of galactose and galactose-1-phosphate in the circulation. As expected, both were found to be signi®cantly elevated at weaning as well as adult age.
Little information is available on pre-pubertal growth in chromosomally competent women who subsequently developed POF. However, retrospective analyses of large series of galactosaemic POF women showed that many affected women had severely delayed growth during childhood and early adolescence, although normal growth and development was also very common (Waggoner et al., 1990) . In a rat model, Chen et al. (1984) demonstrated that galactose toxicity had an adverse impact on intra-uterine embryonic growth. The present investigation, however, documents only a smaller and insigni®cant reduction of mean litter weight at birth, although subsequent growth rates were signi®cantly retarded. This differential growth rate among different galactosaemic women or between the experimental models may be attributed to the difference in magnitude of galactose toxicity. We had observed earlier that feeding rats with a 50% galactose diet, the dosage at which Chen et al. (1981) observed a signi®cantly reduced birth weight of the pups, was associated with a signi®cant reduction in the BW of the dams, and an increased incidence of in-utero fetal resorption and stillbirths. We therefore gradually minimized the galactose content of the diets and considered 35% galactose as the optimum level since it exerted no adverse effect on the mothers' BW and mean litter size was comparable with that of the controls.
With regard to the onset of puberty, there are a number of pertinent observations. Delayed puberty is a frequent ®nding in women with galactosaemia (Fraser et al., 1986) . Late onset of puberty under experimental galactose toxicity has been reported previously (Chen et al., 1981) . The present results also document that the timing of VO, a reproductive tract response to ovarian steroids and one of the key indices for puberty in rodents, was signi®cantly delayed under galactose toxicity. The onset of puberty involves a chain of events including increased production of sex steroids by the gonads in response to increased secretion of gonadotrophins from the anterior pituitary. This is driven by a spurt in the secretion of GnRH following activation of the hypothalamus. Exactly when 
Numbers within parentheses denote numbers of determinations in the corresponding group. Values are mean T SEM. LH values with different superscripts differ signi®cantly at P`0.0001 levels. FSH values differ signi®cantly at the levels of P`0.02, d versus e; P < 0.0001, e versus f. E 2 values with different superscripts differ signi®cantly at P`0.001 levels. 
Numbers within parentheses denote numbers of determinations in the corresponding group. Values are mean T SEM. NE = not estimated. Values in a row with different superscripts differ signi®cantly: a versus b, P < 0.05; c versus d, P = 0.0001; c versus e, P = 0.013; f versus g, P = 0.005.
the puberty-speci®c increase in the cascade of hormones begins largely depends on body size, rather than chronological age (Foster and Nagatani, 1999) . Since the gal-exposed litters had a retarded growth rate, it may be argued that delayed onset of puberty was not a direct effect of galactose toxicity, but rather attributed to delayed growth rate. To resolve the issue, we evaluated VO separately in relation to age and BW. We observed that 63% rats of the study group did not exhibit VO despite their BWs being within the 95% CI of the controls at the time of VO. This observation suggests that galactose toxicity per se is responsible for delayed puberty. Whatever the mechanism, delayed puberty generally results from an ultimate lag in activation of one or more of the factors determining the maturation of the hypothalamo-pituitary±ovarian (HPO) axis (Rosen®eld, 1996) . Observation of elevated gonadotrophins with low circulating levels of E 2 in the study group, however, discounts the possibility of inactivation at the hypothalamopituitary level and points to the ovary as the possible primary target of galactose toxicity. In immature female rats, FSH secretion remains high until PND18 and decreases thereafter (Thyssen and Libertun, 1996) . A subsequent rise in FSH level occurs at the time of VO. This sequential drop and rise of FSH secretion is likely to be of phenomenal importance in the process of onset of puberty. Extended central nervous system (CNS) restraint on GnRH release is considered an attractive hypothesis for delayed puberty (Rosen®eld, 1996) , but prolongation of high FSH by inhibition of polyamine synthesis also delays the onset of puberty independently of body mass (Thyssen and Libertun, 1996) . A drop in FSH during PND18 has been suggested to be a steroid-independent event of cerebral origin, while the rise of gonadotrophins that immediately precedes VO is brought about by a pre-pubertal gradual rise in estrogen secretion that acts at the CNS±pituitary level to trigger a pre-ovulatory pro-estrouslike surge of gonadotrophins (Ojeda et al., 1976) . We demonstrated that the gal-exposed litters had elevated FSH levels both at weaning and at the stipulated peri-pubertal phase; and E 2 levels remained signi®cantly low throughout. It is therefore tempting to speculate that the absence of stimuli in the form of E 2 perhaps blunts the puberty-speci®c sensitization of the CNS±pituitary unit.
Food restriction during late gestation and lactation in rats has been reported to have negative impacts on the HPO axis, and to prohibit follicular maturation and delay the onset of puberty (Leonhardt et al., 2003) . That the rats maintained on our dietary regimen were not underfed or malnourished has been substantiated in our earlier report (Bandyopadhyay et al., 2003) . Moreover, we also maintained the protein content of the galactose diet at 13.65% so that the basic protein requirement (12%) for pregnant rats is met. Therefore, the possibility of any implications of reduced food intake and consequent malnutrition on delayed puberty and related endocrinopathies under galactose toxicity can be ruled out.
Galactosaemia encompasses a broad spectrum of ovarian pathology. While some patients clearly demonstrate ovarian failure related to follicle depletion, others have primordial follicles appearing normal in ovarian biopsy but lacking growth and development (Fraser et al., 1986) . In order to typify the ovarian effects of galactose toxicity, we investigated the ovarian follicular reserve and also evaluated its response to gonadotrophins. Chen et al. (1981) reported that prenatal galactose toxicity led to a signi®cant reduction in the number of small follicles. Our histopathological examination, however, did not reveal such a generalized effect. While many rats suffered from de®cient follicular reserve, others exhibited apparently normal follicular complement, though they were unresponsive to exogenous gonadotrophins. Thus the basic tenets of the diverse phenotypes of POF are also conserved in experimental galactose toxicity.
The size of a follicular complement at any point of reproductive life represents the balance between the numbers of follicles endowed in the initial ovarian pool and those expended since then. A de®cient follicular reserve may therefore ensue from an under-endowment of follicles in the ovarian pool and/or an accelerated rate of atresiaÐthe major form of follicular expenditure. Within the reproductive system, the ovary is considered to be one of the major targets of galactose metabolites that have detrimental effects on the germ cells, granulosa cells, stromal cells and thecal cells (Kaufman et al., 1987 (Kaufman et al., , 1989 Gibson, 1995) . Fraser et al. (1986) demonstrated that ovarian accumulation of galactose-1-phosphate led to degradation of uridine nucleotides and induced follicular atresia. In the present study, we observed a general preponderance of atretic secondary follicles in the gal-exposed group. On the other hand, we have demonstrated recently that galactose toxicity adversely affected germ cell migration leading to ovary development with a low initial pool of germ cells (Bandyopadhyay et al., 2003) . We therefore suggest that an increased rate of atresia as well as a de®cient initial ovarian pool of germ cells are implicated in the process of premature depletion of follicles under galactose toxicity.
The state of hypergonadotrophic hypoestrogenism in the presence of an apparently normal complement of follicles under galactose toxicity attests to the state of follicular refractoriness to gonadotrophins. There are, however, suggestions that in galactosaemic women, some aberrant forms of gonadotrophins are produced that are biologically inactive (Prestoz et al, 1997) . In order to replace such putative defective gonadotrophins, we induced superovulation in rats by exogenous gonadotrophins. Ovarian response, expressed in terms of the number of rats exhibiting ovulation or the number of oocytes ovulated per rat, was signi®cantly poorer in the study group. It was not surprising that ovaries with de®cient follicles responded poorly to gonadotrophins. However, it was signi®-cant that post-autopsy histological analysis of the gonadotrophin-exposed ovaries showed them to possess an apparently normal complement of unstimulated follicles (data not shown). If reduced biopotency of the endogenous gonadotrophins were the sole factor responsible for follicular refractoriness, these follicles should have responded to the exogenous gonadotrophins. In order to look for additional factor(s), we carried out the induction of superovulation after pituitary desensitization with chronic administration of GnRH agonist. The objective was to assess the ovarian response to exogenous gonadotrophins without any intervening effects of endogenous gonadotrophins. A signi®cant increase in ovarian response in the GnRH-downregulated group raises the possibility that endogenous gonadotrophins had also exerted anti-gonadotrophic activity, presumably at the receptor level. It may, however, be relevant in this context that in galactosaemic patients, some neutral isoforms of FSH are produced that are partially de®cient in galactose and sialic acid in the carbohydrate side chains (Prestoz et al., 1997) . These altered forms of FSH are characterized by their higher binding af®nity for FSH receptors but reduced ability to activate the second messenger system. By virtue of this property, these isoforms of FSH may act as anti-hormones and produce antagonistic effects at the receptor level (Sairam, 1989) .
Earlier workers have proposed some genetically engineered mouse models for POF. Pellas et al. (1991) described an insertional mutation in mouse that caused a de®ciency of primordial germ cells reaching the genital ridge during embryonic development. Dong et al. (1996) effected targeted deletion using stem cell technology to produce growth differentiation factor-9 (GDF-9)-de®cient mice that had unhindered formation of primordial and primary follicles but suffered from follicular development beyond the primary one-layer stage. Both of these experimental conditions could potentially be valuable animal model for human POF. However, if the diverse phenotypes of POF are taken into consideration, each model has its own limitations. A germ cellde®cient mouse may be reminiscent of only the phenotype of the follicle depletion type of POF, while a GDF-9-de®cient mouse has the potential to be a model for the follicle dysfunction type of POF. However, galactose toxicity is unique in that it encompasses both spectra of the disease.
Finally, diverse aetiology and multifaceted phenotypes of POF limit the potential of a single model in encompassing the full spectrum of the pathogenesis of the disease. Importantly, however, in view of the foregoing, we are left with the conclusion that experimental galactose toxicity has the credentials to serve as a model at least to explore some of the basic tenets of POF/ROS irrespective of aetiology.
